BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32829726)

  • 41. COVID-19 pandemic: personal view to a new model of pediatric practice.
    Barsoum Z
    World J Pediatr; 2020 Aug; 16(4):428. PubMed ID: 32524375
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
    Flinck H; Aittoniemi J
    J Virol Methods; 2023 Sep; 319():114758. PubMed ID: 37263352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia.
    Abrahim SA; Tessema M; Defar A; Hussen A; Ejeta E; Demoz G; Tereda AB; Dillnessa E; Feleke A; Amare M; Nigatu F; Fufa Y; Refera H; Aklilu A; Kassa M; Kifle T; Whiting S; Tollera G; Abate E
    PLoS One; 2020; 15(12):e0244269. PubMed ID: 33378367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens.
    Wang H; Hogan CA; Miller JA; Sahoo MK; Huang C; Mfuh KO; Sibai M; Zehnder J; Hickey B; Sinnott-Armstrong N; Pinsky BA
    Emerg Infect Dis; 2021 Jan; 27(1):92-103. PubMed ID: 33183494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of SARS and COVID-19 outbreaks on urology practice and training.
    Yee CH; Wong HF; Tam MHM; Yuen SKK; Chan HC; Cheung MH; Yu ATO; Chiu Y; Chan NH; Leung LH; Ng ATL; Law DMC; Ng TL; Teoh JYC; Chiu PKF; Ng CF
    Hong Kong Med J; 2021 Aug; 27(4):258-265. PubMed ID: 33632937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 Nucleocapsid Plasma Antigen for Diagnosis and Monitoring of COVID-19.
    Wang H; Hogan CA; Verghese M; Solis D; Sibai M; Huang C; Röltgen K; Stevens BA; Yamamoto F; Sahoo MK; Zehnder J; Boyd SD; Pinsky BA
    Clin Chem; 2021 Dec; 68(1):204-213. PubMed ID: 34605900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. COVID-19 in the New York City Jail System: Epidemiology and Health Care Response, March-April 2020.
    Chan J; Burke K; Bedard R; Grigg J; Winters J; Vessell C; Rosner Z; Cheng J; Katyal M; Yang P; MacDonald R
    Public Health Rep; 2021 May; 136(3):375-383. PubMed ID: 33673760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative Performance of Four Nucleic Acid Amplification Tests for SARS-CoV-2 Virus.
    Zhuang QZ; Li ZZ; Chao Y; Li F; Ge YY; Sha YH; Wang Y; Huang XZ; Ke PF; Xiong YJ
    Clin Lab; 2021 Jul; 67(7):. PubMed ID: 34258963
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three SARS-CoV-2 PCR-negative cases of COVID-19 diagnosed using isothermal amplification methods.
    Shinozawa S; Moriyama Y
    J Infect Chemother; 2022 Jul; 28(7):1005-1007. PubMed ID: 35430091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant.
    Mlcochova P; Collier D; Ritchie A; Assennato SM; Hosmillo M; Goel N; Meng B; Chatterjee K; Mendoza V; Temperton N; Kiss L; James LC; Ciazynska KA; Xiong X; Briggs JAG; Nathan JA; Mescia F; Bergamaschi L; Zhang H; Barmpounakis P; Demeris N; Skells R; Lyons PA; Bradley J; Baker S; Allain JP; Smith KGC; Bousfield R; Wilson M; Sparkes D; Amoroso G; Gkrania-Klotsas E; Hardwick S; Boyle A; Goodfellow I; Gupta RK;
    Cell Rep Med; 2020 Sep; 1(6):100099. PubMed ID: 32905045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical appropriateness and economics of nucleic acid amplification testing for infectious diseases.
    Doron S; Horowitz G
    Clin Biochem; 2023 Jul; 117():48-52. PubMed ID: 35489474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission from Patients With Undiagnosed Coronavirus Disease 2019 (COVID-19) to Roommates in a Large Academic Medical Center.
    Karan A; Klompas M; Tucker R; Baker M; Vaidya V; Rhee C
    Clin Infect Dis; 2022 Mar; 74(6):1097-1100. PubMed ID: 34145449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Yield of Severe Acute Respiratory Syndrome Coronavirus 2 Lower Respiratory Tract Testing After a Negative Nasopharyngeal Test Among Hospitalized Persons Under Investigation for Coronavirus Disease 2019.
    Egbuonu K; Hyle EP; Hurtado RM; Alba GA; Zachary KC; Branda JA; Hibbert KA; Hooper DC; Shenoy ES; Turbett SE; Dugdale CM
    Open Forum Infect Dis; 2021 Jun; 8(6):ofab257. PubMed ID: 34113690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceptance of a Symptom-Based Approach for COVID-19 rtRT-PCR Testing to Conserve Resources in a Lower Middle-Income Setting.
    Islam SMRU; Akther T; Nasif MAO; Sultana S; Munshi SU
    J Prim Care Community Health; 2021; 12():2150132720987711. PubMed ID: 33525985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
    Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retrospective evaluation of clinical decision support for within-laboratory optimization of SARS-CoV-2 NAAT workflow.
    Durant TJS; Peaper DR
    J Clin Microbiol; 2024 Feb; 62(2):e0078523. PubMed ID: 38132702
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2.
    Bulterys PL; Garamani N; Stevens B; Sahoo MK; Huang C; Hogan CA; Zehnder J; Pinsky BA
    J Clin Virol; 2020 Aug; 129():104427. PubMed ID: 32535398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of asthma during the Coronavirus disease 2019 outbreak.
    Taillé C; Chenivesse C; Devouassoux G; Bourdin A; Garcia G; ;
    Respir Med Res; 2020 Nov; 78():100762. PubMed ID: 32805635
    [No Abstract]   [Full Text] [Related]  

  • 60. Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.
    Safiabadi Tali SH; LeBlanc JJ; Sadiq Z; Oyewunmi OD; Camargo C; Nikpour B; Armanfard N; Sagan SM; Jahanshahi-Anbuhi S
    Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.